A model for the rapid development of dispositional and functional tolerance to barbiturates.
The s.c. implantation of a 75 mg pentobarbital pellet in the back of a conscious mouse resulted in a much more rapid development of tolerance to barbiturates than that produced in mice receiving daily i.p. injections of 75 mg/kg sodium pentobarbital. Acceleration in tolerance development by pentobarbital pellet implantation was evidenced by a decrease in sleeping time after the challenge with either sodium pentobarbital or sodium barbital. The degree of hepatic microsomal drug enzyme induction after pentobarbital pellet implantation also was found to be significantly higher than that produced by the injection technique. Further studies demonstrated that the threshold for pentylenetetrazol-induced seizures was significantly reduced compared to that of the sodium pentobarbital daily injected and control groups. These studies provide an animal model for studying the mechanism of barbiturate tolerance and dependence.
D000818:Animals; D001463:Barbiturates / Q000494:pharmacology*; D004361:Drug Tolerance; D006207:Half-Life; D006801:Humans; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008862:Microsomes, Liver / Q000378:metabolism; D008954:Models, Biological; D010424:Pentobarbital / Q000378:metabolism / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced; D019966:Substance-Related Disorders
D001463:Barbiturates; D010424:Pentobarbital; D010433:Pentylenetetrazole